Skip to content

Medicated Enema And Virechan Karma Along With Shamana Therapy In The Management Of Post Chikungunya Chronic Inflammatory Rheumatism

A comparative study to evaluate the effect of Virechana Karma and Kaala Basti along with Shamana therapy in the management of post-chikungunya chronic inflammatory rheumatism- An Open Labelled Randomized Comparative Clinical Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025754
Enrollment
90
Registered
2020-06-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: M064- Inflammatory polyarthropathy

Interventions

Intervention1: Virechana Karma and Shamana Therapy: In this group A patients will be treated with Virechana karma with Erand Taila followed by Shamana therapy with Rasnapanchaka kwath for 30 days Cont

Sponsors

Institute For Post Graduate Training And Research In Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Confirm case of Chikungunya fever with symptoms of pCHIK-CIR like pain in joints, swelling, stiffness, restricted movements etc Patients Yogya for Virechana and Basti Karma Patient willing to participate in the trial will be included

Exclusion criteria

Exclusion criteria: patients below 18 years and above 70 years of age patients suffering from Malignant and accelerated hypertension, coronary artery disease, uncontrolled diabetes. History of R.A., Gout, Psoriatic arthritis, rheumatic fever, autoimmune disease, SLE before Chikungunya fever, Pregnant and lactating women, Patient undergoing regular treatment for any other severe illness and also patients suffering from pulmonary tuberculosis or bone tuberculosis, carcinoma and HIV positive patients

Design outcomes

Primary

MeasureTime frame
Pain Management In Post-Chikungunya Chronic Inflammatory Rheumatism (PCHIK-CIR)Timepoint: Approx 40-60 Days

Secondary

MeasureTime frame
Relief in sign and symptoms of Post-Chikungunya chronic inflammatory rheumatism (pCHIK-CIR)Timepoint: Approx 40-60 days

Countries

India

Contacts

Public ContactProf Anup B Thakar

Institute For Post Graduate Teaching And Research In Ayurveda, Gujarat Ayurved University

anup_thakar@yahoo.com9427776660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026